Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

August 31, 2013

Conditions

Fistulizing Crohn's Disease

Interventions

DRUG

DLX105

10mg DLX105/injection injected into the fistula over a treatment period of 4 weeks.

DRUG

Placebo

Placebo injections are administered over the treatment period of 4 weeks.

Trial Locations (1)

University Hospital, Zurich